Suppr超能文献

丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂2型的细胞内聚合

Intracellular polymerization of the serpin plasminogen activator inhibitor type 2.

作者信息

Mikus P, Ny T

机构信息

Department of Medical Biochemistry and Biophysics, Umeå University, S-901 87 Umeå, Sweden.

出版信息

J Biol Chem. 1996 Apr 26;271(17):10048-53. doi: 10.1074/jbc.271.17.10048.

Abstract

Plasminogen activator inhibitor type 2 (PAI-2) is synthesized in two molecular forms: an intracellular, nonglycosylated form and an extracellular, glycosylated form. The bitopological distribution of PAI-2 is caused by an inefficient internal secretion signal. In addition, the secretion efficiency of PAI-2 seems to differ, depending on the cell type, differentiation state, and culture conditions. In recombinant cell clones designed for the synthesis of the secreted form of PAI-2, the fraction of secreted PAI-2 decreased with increasing expression levels. Subcellular fractionation of cell clones with higher expression levels revealed that PAI-2 accumulating in the cell was mainly associated with the organelles of the secretory pathway. Electrophoresis under nondenaturating conditions revealed that the PAI-2 retained at higher expression levels was mainly polymerized. Polymers of PAI-2 were also detected in cytosolic extracts prepared from human placenta and phorbol ester-stimulated U 937 cells, indicating that intracellular polymerization of PAI-2 may occur in the cytosols of cells that normally express PAI-2 under physiological conditions. When purified PAI-2 or cellular extracts were incubated at 37 degrees C for 24 h most of the PAI-2 protein was found to polymerize. Polymer formation was prevented by the addition of synthetic peptides with sequences corresponding to residues P2 to P14 in the reactive center loop of PAI-2 and antithrombin. These synthetic peptides also caused dissociation of prepolymerized purified PAI-2 and PAI-2 polymers in cellular extracts. Incubation with unrelated peptides of the same size had no effect on polymer formation or dissociation of preformed polymers, indicating that polymerization of PAI-2 occurs by the loop-sheet mechanism. Taken together, our data suggest that the wild-type form of PAI-2, like some natural pathological genetic variants of alpha1-antitrypsin, antithrombin, and C1 inhibitor readily polymerizes intracellularly and that polymerization may lead to a reduced secretion efficiency.

摘要

纤溶酶原激活物抑制剂2(PAI-2)以两种分子形式合成:一种是细胞内的非糖基化形式,另一种是细胞外的糖基化形式。PAI-2的双拓扑分布是由低效的内部分泌信号引起的。此外,PAI-2的分泌效率似乎因细胞类型、分化状态和培养条件而异。在设计用于合成分泌型PAI-2的重组细胞克隆中,分泌型PAI-2的比例随着表达水平的增加而降低。对表达水平较高的细胞克隆进行亚细胞分级分离发现,细胞内积累的PAI-2主要与分泌途径的细胞器相关。非变性条件下的电泳显示,在较高表达水平下保留的PAI-2主要是聚合的。在从人胎盘和佛波酯刺激的U 937细胞制备的胞质提取物中也检测到了PAI-2聚合物,这表明在生理条件下正常表达PAI-2的细胞胞质中可能发生PAI-2的细胞内聚合。当纯化的PAI-2或细胞提取物在37℃孵育24小时时,发现大多数PAI-2蛋白发生了聚合。通过添加与PAI-2和抗凝血酶反应中心环中P2至P14残基序列相对应的合成肽,可以防止聚合物形成。这些合成肽还导致预聚合的纯化PAI-2和细胞提取物中的PAI-2聚合物解离。与相同大小的无关肽孵育对聚合物形成或预形成聚合物的解离没有影响,这表明PAI-2的聚合是通过环-片层机制发生的。综上所述,我们的数据表明,PAI-2的野生型形式,与α1-抗胰蛋白酶、抗凝血酶和C1抑制剂某些天然病理性遗传变体一样,很容易在细胞内发生聚合,并且聚合可能导致分泌效率降低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验